» Articles » PMID: 19637245

Anxiety and Distress During Active Surveillance for Early Prostate Cancer

Overview
Journal Cancer
Publisher Wiley
Specialty Oncology
Date 2009 Jul 29
PMID 19637245
Citations 69
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Patients on active surveillance (AS) for early prostate cancer (PC) may experience feelings of anxiety and distress while living with "untreated" cancer. In this study, these feelings were quantified, and their associations with various psychologic, medical, demographic, and decision-related factors were assessed.

Methods: Men with recently diagnosed PC who participated in a prospective protocol-based AS program (the Prostate Cancer Research International: Active Surveillance study [PRAIS]) received a questionnaire (N = 150). Scores concerning decisional conflict (the Decisional Conflict Scale), depression (the Center for Epidemiologic Studies Depression Scale), generic anxiety (the abridged State-Trait Anxiety Inventory), and PC-specific anxiety (the Memorial Anxiety Scale for Prostate Cancer) were compared with reference values and the literature. Associations with scores on physical health (the Medical Outcomes Study 12-item short-form Physical Component Summary), personality (the Eysenck Personality Questionnaire), shared decision-making, knowledge of PC, and demographic and medical parameters were determined with univariate and multivariate linear regression analyses.

Results: The questionnaire response rate was 86% (129 of 150 men). Of all respondents, 81%, 92%, 83%, and 93% scored better than reference values for clinically significant uncertainty regarding the treatment decision, depression, generic anxiety, and PC-specific anxiety, respectively. Scores were comparable to or more favorable than those of men (reported in literature) who underwent other treatments for localized PC. In multivariate analysis, the following associations emerged: a perceived important role of the physician in shared decision-making was associated with higher decisional conflict, better physical health was associated with lower depression, neurotic personality was associated with higher depression and with generic and PC-specific anxiety, and higher prostate-specific antigen level was associated with higher PC-specific anxiety.

Conclusions: Men on protocol-based AS mainly reported favorable levels of anxiety and distress. A neurotic personality score was associated with unfavorable effects. These findings may help to optimize patient selection for AS or to select men for supportive measures.

Citing Articles

Whole gland versus partial gland ablation in patients with localized prostate cancer treated by high-intensity focused ultrasound ablation.

Lee H, Song S, Lee H, Hong S Prostate Int. 2024; 12(4):213-218.

PMID: 39735197 PMC: 11681343. DOI: 10.1016/j.prnil.2024.09.001.


Characteristics Predicting Short-Term and Long-Term Health-Related Quality of Life in Patients with Esophageal Cancer After Neoadjuvant Chemoradiotherapy and Esophagectomy.

van der Wilk B, Eyck B, Noordman B, Kranenburg L, Oppe M, Lagarde S Ann Surg Oncol. 2023; 30(13):8192-8202.

PMID: 37587357 PMC: 10625935. DOI: 10.1245/s10434-023-14028-8.


Fear of Cancer Recurrence and Coping Strategies among Prostate Cancer Survivors: A Qualitative Study.

Mardani A, Ashghali Farahani M, Khachian A, Vaismoradi M Curr Oncol. 2023; 30(7):6720-6733.

PMID: 37504353 PMC: 10378434. DOI: 10.3390/curroncol30070493.


Trajectory of Depression among Prostate Cancer Patients: A Secondary Analysis of a Randomized Controlled Trial.

Chhatre S, Gallo J, Guzzo T, Morales K, Newman D, Vapiwala N Cancers (Basel). 2023; 15(7).

PMID: 37046786 PMC: 10092991. DOI: 10.3390/cancers15072124.


Patient preferences for active surveillance vs standard surgery after neoadjuvant chemoradiotherapy in oesophageal cancer treatment: The NOSANO-study.

Hermus M, van der Wilk B, Chang R, Collee G, Noordman B, Coene P Int J Cancer. 2022; 152(6):1183-1190.

PMID: 36250325 PMC: 10092042. DOI: 10.1002/ijc.34327.